The Supreme Court has agreed to consider whether pharmaceutical sales
representatives can bill their employers for overtime, a case that could
affect the pay of tens of thousands of people.
The court said Monday that it will review a federal appeals court ruling
that held the sales reps do not qualify for overtime under federal
labor law. Other appeals courts have ruled differently and the
pharmaceutical industry joined in the call for Supreme Court review.
The sales reps meet with physicians in the hope that doctors will
prescribe one company's medicine over another's. Two salesmen who once
worked for drug maker GlaxoSmithKline filed a class-action lawsuit
claiming that they were not paid for the 10 to 20 hours they worked each
week on average outside the normal business day.
No comments:
Post a Comment